Topics
November/December 2012 | Treatment Of Retinoblastoma In The First 3 Months Of Life: Bridge Therapy
Treatment of Retinoblastoma in the First 3 Months of Life: Bridge Therapy
David H. Abramson, MD, FACS
August 7, 2026
UK Study Finds Ophthalmic Clinical Letters Increasingly Difficult for Patients to Read
August 6, 2026
Norlase Expands European Footprint with Direct Sales Model in Germany
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals
August 5, 2026
Vantage Biosciences Completes Enrollment in Phase 2 SeeClear Trial of Oral NPDR Therapy
July/August 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
July/August 2026 Supplement
Editorially Independent Content, Supported With Advertising From Astellas and ZEISS
July 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
_1784132761.jpg?auto=compress,format&w=70)
